Cold atmospheric plasma for addressing the COVID‐19 pandemic

ABSTRACT

The coronavirus disease 2019 (COVID‐19) pandemic has greatly stressed the global community, exposing vulnerabilities in the supply chains for disinfection materials, personal protective equipment, and medical resources worldwide. Disinfection methods based on cold atmospheric plasma (CAP) technologies offer an intriguing solution to many of these challenges because they are easily deployable and do not require resource‐constrained consumables or reagents needed for conventional decontamination practices. CAP technologies have shown great promise for a wide range of medical applications from wound healing and cancer treatment to sterilization methods to mitigate airborne and fomite transfer of viruses. This review engages the broader community of scientists and engineers that wish to help the medical community with the ongoing COVID‐19 pandemic by establishing methods to utilize broadly applicable CAP technologies. Pandemics such as coronavirus disease 2019 (COVID‐19) can benefit from disinfection methods based on cold atmospheric plasma (CAP) technologies that are easily deployable, easily accessed, and sustainable. CAP technologies have shown great promise for a wide range of medical applications from wound healing and cancer treatment to sterilization methods to mitigate airborne and fomite transfer of viruses. Therefore, CAP is an attractive resource for the future of controlling viruses such as those causing the COVID‐19 pandemic.